LimmaTech Biologics AG
Silvia Napolitano, PhD, currently holds a position in the clinical team at LimmaTech Biologics AG with rotational duties, focusing on preparing and conducting vaccine clinical trials. Previous experience includes a role as a Research Scientist at the same company, where responsibilities encompassed project management, interdepartmental coordination, and biosafety compliance. Silvia’s academic background features a PhD in Biology from ETH Zürich, complemented by extensive research experience in molecular biology and biochemical techniques from institutions including ETH Zürich, the University of Konstanz, Consiglio Nazionale delle Ricerche, and Università di Pavia. Demonstrated skills include experimental design, collaboration facilitation, and strong analytical capabilities, illustrated by participation in international conferences and successful project management throughout the research career.
This person is not in any teams
LimmaTech Biologics AG
LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK.